What blood tests are used to diagnose type 1 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Tests for Diagnosing Type 1 Diabetes

Plasma glucose tests, rather than HbA1c, should be used as the primary diagnostic tests for acute onset of type 1 diabetes in individuals with symptoms of hyperglycemia. 1

Primary Diagnostic Tests

  • Fasting Plasma Glucose (FPG): A value ≥126 mg/dL (7.0 mmol/L) after at least 8 hours of fasting is diagnostic for diabetes 2, 1
  • 2-hour Plasma Glucose: A value ≥200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test (OGTT) using 75g of anhydrous glucose is diagnostic 2, 1
  • Random Plasma Glucose: A value ≥200 mg/dL (11.1 mmol/L) in patients with classic symptoms of hyperglycemia (polyuria, polydipsia, unexplained weight loss) or hyperglycemic crisis is diagnostic 2, 1

Autoantibody Testing

  • Islet Autoantibodies: Testing for autoantibodies is recommended to confirm the autoimmune nature of type 1 diabetes, especially in adults with overlapping phenotypic risk factors 2, 1
  • Specific Autoantibodies to Test:
    • Islet cell autoantibodies (ICA) 1
    • Glutamic acid decarboxylase autoantibodies (GAD65) 2, 1
    • Insulin autoantibodies 2, 1
    • Tyrosine phosphatase autoantibodies (IA-2 and IA-2β) 2, 1
    • Zinc transporter 8 autoantibodies (ZnT8) 2, 1
  • The presence of one or more of these autoimmune markers defines type 1 diabetes 2
  • Multiple positive autoantibodies strongly predict clinical diabetes development 2

Beta-Cell Function Assessment

  • C-peptide: Measuring C-peptide levels is recommended to assess beta-cell function; low or undetectable levels are characteristic of type 1 diabetes 1

Confirmation Requirements

  • Unless there is a clear clinical diagnosis (e.g., patient in hyperglycemic crisis or with classic symptoms plus random glucose ≥200 mg/dL), diagnosis requires two abnormal test results 2
  • Confirmation can be achieved through:
    • Two abnormal results from the same sample 2
    • Two abnormal results from separate test samples 2
    • Two different tests (such as FPG and A1C) both above diagnostic thresholds 2

Special Considerations

  • Ketone Testing: Blood or urine ketone testing should be performed when type 1 diabetes is suspected, as approximately one-third of patients present with diabetic ketoacidosis (DKA) 1
  • Timing of Tests: Morning FPG values tend to be higher than afternoon values (5.41 vs. 5.12 mmol/L), which may affect diagnosis if testing is done in the afternoon 3
  • Sample Handling: For plasma glucose tests, samples should be spun and separated immediately after drawing to prevent preanalytic variability 2

Limitations of HbA1c Testing

  • HbA1c should not be used as the sole diagnostic test for acute onset type 1 diabetes 1
  • HbA1c testing is unreliable in conditions affecting red blood cell turnover, such as:
    • Hemoglobinopathies 2
    • Pregnancy (second and third trimesters) 2
    • Glucose-6-phosphate dehydrogenase deficiency 2
    • Hemodialysis 2
    • Recent blood loss or transfusion 2
    • Erythropoietin therapy 2

Screening for Type 1 Diabetes Risk

  • Screening with autoantibody panels is currently recommended only in research settings or for first-degree family members of individuals with type 1 diabetes 2, 1
  • Persistence of two or more autoantibodies is a significant risk factor for developing clinical diabetes 2, 1

References

Guideline

Diagnosis of Type 1 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.